Haili Bio to list restricted shares after lock-up

Shanghai Hile Bio-Technology (SSE:603718) announced the upcoming listing and circulation of 4,979,700 restricted shares on February 18, 2025. These shares are tied to the company’s 2023 restricted stock and stock option incentive plan, marking the first unlock for participating employees. The move affects 51 eligible employees, following a board review confirming the achievement of pre-set performance targets. While most participants met individual performance goals, 27 employee share awards and those of six employees at headquarters are being partially clawed back due to performance shortfalls. The company stated it is processing the return and cancellation of these shares, which should not impact calculation of circulation.